InvestorsHub Logo
Followers 69
Posts 6664
Boards Moderated 0
Alias Born 02/10/2010

Re: Steve43 post# 164684

Thursday, 12/13/2018 1:52:36 PM

Thursday, December 13, 2018 1:52:36 PM

Post# of 333754
Spend some time over on the ENDV Board. They are in the same shape as BIEL as far as operating on a very limited budget. They did not develop the Sofpulse, they bought the rights from Rio Grande a year ago. Rio Grande sold because after 9 years they had not made the 'prescription model' profitable with Sofpulse.

Moving to the 'OTC model' is absolutely the right business plan for ActiPatch to pursue.